EFFICACY OF TOPICAL 5% IMIQUIMOD WITH CRYOTHERAPY VERSUS INTRALESIONAL MEGLUMINE ANTIMONIATE IN THE TREATMENT OF ANTHROPONOTIC CUTANEOUS LEISHMANIASIS

Editorial offiCE Ali Asilian, MD, Isfahan, Iran Mir Hadi Aziz-Jalali: MD, Tehran,Iran Celalettin R. Celebi, MD, Ankara, Turkey Cheyda Chams-Davatchi, MD, Tehran, Iran Maryam Daneshpazhooh, MD, Tehran, Iran Yahya Dowlati, MD, PHD, Tehran, Iran Hee Chul Eun, MD, Seoul, Korea Mahmoud Farshcian, MD, Hamedan, Iran Alireza Firooz, MD, Tehran,Iran Christoph C. Geilen, MD, Berlin, Germany Aziz Ghahary, PhD, Vancouver, Canada Reza Ghohestani, MD, PhD, SanAntonio, USA Farhad Handjani, MD, Shiraz, Iran Hemangi Jerajani, MD, Mumbaie, India David A. Mehregan, MD, Monroe, USA Ali Khamesipour, PhD, Tehran, Iran Farhad Malekzad, MD, Tehran, Iran Parvin Mansouri, MD, Tehran, Iran Mohammad Javad Nazemi, MD, Tehran, Iran Soheila Nassiri, MD, Tehran, Iran Mansour Nassiri Kashani, MD, Tehran, Iran Koushik Lahiri, MD, Kalkata, India Mohammad Ali Nilforoosh Zadeh, MD, Tehran, Iran Constantin E. Orfanos, MD, Berlin, Germany Terrence Ryan, MD, Oxford, UK Parvaneh Saket, MD, Tehran, Iran Mohammad Shahidi-Dadras: MD, Tehran,Iran Saad-Allah Shamsaddini, MD, Kerman, Iran Bahram Sina, MD, Baltimore, USA Robert A. Schwartz, MD, MPH, Newark, USA Hossein Tabatabaei, MD, Tehran, Iran Agneta Troilius, MD, Malmoe, Sweden Mahin Valikhani, MD, Tehran, Iran Shyam Verma, MD, Vadodara, India Luitgard G. Wiest, MD, Munich, Germany Reza Yaghoobi, MD, Ahvaz, Iran